Clinical features of long-term survivors over 40 years old with Duchenne muscular dystrophy

Clinical features of long-term survivors over 40 years old with Duchenne muscular dystrophy - Clinical features of long-term survivors over 40 years old with Duchenne muscular dystrophy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017322

Enrollment

118

Registered

2015-04-29

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne muscular dystrophy (DMD)

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: DMD patients aged over 40 year of age at the time of the search on July 1, 2013. They are recruited based on the Muscular dystrophy wards database of 2012.

Exclusion criteria

Exclusion criteria: DMD patients under 40 years of age at the time of the database search in July 2013 are excluded.

Design outcomes

Primary

Measure	Time frame
Method and result of gene analysis. Muscle biopsy findings. Age of loss of independent ambulation. Status of cardiomyopathy ( EF of echocardiograph and plasma BNP). Kinds of agents used for treatment for cardiomyopathy. History of steroid therapy (used, not used, or now using). History of spinal fusion operation (done, not done). Central nervous symptom (mental retardation, autistic disorder, epilepsy, and so on). Other matter worthy of special mention.	—

Measure

Time frame

Method and result of gene analysis. Muscle biopsy findings. Age of loss of independent ambulation. Status of cardiomyopathy ( EF of echocardiograph and plasma BNP). Kinds of agents used for treatment for cardiomyopathy. History of steroid therapy (used, not used, or now using). History of spinal fusion operation (done, not done). Central nervous symptom (mental retardation, autistic disorder, epilepsy, and so on). Other matter worthy of special mention.

—

Countries

Japan

Contacts

Public ContactToshio Saito

National Hospital Organization Toneyama National Hospital Division of Child Neurology, Department of Neurology

saitot@toneyama.go.jp06-6853-2001

Outcome results